Table of Contents Executive Summary 1 Industry Overview of Neuroendocrine Carcinoma Drugs 1.1 Definition of Neuroendocrine Carcinoma Drugs 1.2 Neuroendocrine Carcinoma Drugs Segment by Type 1.2.1 Global Neuroendocrine Carcinoma Drugs Production Growth Rate Comparison by Types (2014-2025) 1.2.2 Somatostatin Analogs 1.2.3 Targeted Therapy 1.2.4 Chemotherapy 1.3 Neuroendocrine Carcinoma Drugs Segment by Applications 1.3.1 Global Neuroendocrine Carcinoma Drugs Consumption Comparison by Applications (2014-2025) 1.3.2 Hospital 1.3.3 Clinics 1.3.4 Oncology Centres 1.3.5 Ambulatory Surgery Centres 1.4 Global Neuroendocrine Carcinoma Drugs Overall Market 1.4.1 Global Neuroendocrine Carcinoma Drugs Revenue (2014-2025) 1.4.2 Global Neuroendocrine Carcinoma Drugs Production (2014-2025) 1.4.3 North America Neuroendocrine Carcinoma Drugs Status and Prospect (2014-2025) 1.4.4 Europe Neuroendocrine Carcinoma Drugs Status and Prospect (2014-2025) 1.4.5 China Neuroendocrine Carcinoma Drugs Status and Prospect (2014-2025) 1.4.6 Japan Neuroendocrine Carcinoma Drugs Status and Prospect (2014-2025) 1.4.7 Southeast Asia Neuroendocrine Carcinoma Drugs Status and Prospect (2014-2025) 1.4.8 India Neuroendocrine Carcinoma Drugs Status and Prospect (2014-2025) 2 Manufacturing Cost Structure Analysis 2.1 Raw Material and Suppliers 2.2 Manufacturing Cost Structure Analysis of Neuroendocrine Carcinoma Drugs 2.3 Manufacturing Process Analysis of Neuroendocrine Carcinoma Drugs 2.4 Industry Chain Structure of Neuroendocrine Carcinoma Drugs 3 Development and Manufacturing Plants Analysis of Neuroendocrine Carcinoma Drugs 3.1 Capacity and Commercial Production Date 3.2 Global Neuroendocrine Carcinoma Drugs Manufacturing Plants Distribution 3.3 Major Manufacturers Technology Source and Market Position of Neuroendocrine Carcinoma Drugs 3.4 Recent Development and Expansion Plans 4 Key Figures of Major Manufacturers 4.1 Neuroendocrine Carcinoma Drugs Production and Capacity Analysis 4.2 Neuroendocrine Carcinoma Drugs Revenue Analysis 4.3 Neuroendocrine Carcinoma Drugs Price Analysis 4.4 Market Concentration Degree 5 Neuroendocrine Carcinoma Drugs Regional Market Analysis 5.1 Neuroendocrine Carcinoma Drugs Production by Regions 5.1.1 Global Neuroendocrine Carcinoma Drugs Production by Regions 5.1.2 Global Neuroendocrine Carcinoma Drugs Revenue by Regions 5.2 Neuroendocrine Carcinoma Drugs Consumption by Regions 5.3 North America Neuroendocrine Carcinoma Drugs Market Analysis 5.3.1 North America Neuroendocrine Carcinoma Drugs Production 5.3.2 North America Neuroendocrine Carcinoma Drugs Revenue 5.3.3 Key Manufacturers in North America 5.3.4 North America Neuroendocrine Carcinoma Drugs Import and Export 5.4 Europe Neuroendocrine Carcinoma Drugs Market Analysis 5.4.1 Europe Neuroendocrine Carcinoma Drugs Production 5.4.2 Europe Neuroendocrine Carcinoma Drugs Revenue 5.4.3 Key Manufacturers in Europe 5.4.4 Europe Neuroendocrine Carcinoma Drugs Import and Export 5.5 China Neuroendocrine Carcinoma Drugs Market Analysis 5.5.1 China Neuroendocrine Carcinoma Drugs Production 5.5.2 China Neuroendocrine Carcinoma Drugs Revenue 5.5.3 Key Manufacturers in China 5.5.4 China Neuroendocrine Carcinoma Drugs Import and Export 5.6 Japan Neuroendocrine Carcinoma Drugs Market Analysis 5.6.1 Japan Neuroendocrine Carcinoma Drugs Production 5.6.2 Japan Neuroendocrine Carcinoma Drugs Revenue 5.6.3 Key Manufacturers in Japan 5.6.4 Japan Neuroendocrine Carcinoma Drugs Import and Export 5.7 Southeast Asia Neuroendocrine Carcinoma Drugs Market Analysis 5.7.1 Southeast Asia Neuroendocrine Carcinoma Drugs Production 5.7.2 Southeast Asia Neuroendocrine Carcinoma Drugs Revenue 5.7.3 Key Manufacturers in Southeast Asia 5.7.4 Southeast Asia Neuroendocrine Carcinoma Drugs Import and Export 5.8 India Neuroendocrine Carcinoma Drugs Market Analysis 5.8.1 India Neuroendocrine Carcinoma Drugs Production 5.8.2 India Neuroendocrine Carcinoma Drugs Revenue 5.8.3 Key Manufacturers in India 5.8.4 India Neuroendocrine Carcinoma Drugs Import and Export 6 Neuroendocrine Carcinoma Drugs Segment Market Analysis (by Type) 6.1 Global Neuroendocrine Carcinoma Drugs Production by Type 6.2 Global Neuroendocrine Carcinoma Drugs Revenue by Type 6.3 Neuroendocrine Carcinoma Drugs Price by Type 7 Neuroendocrine Carcinoma Drugs Segment Market Analysis (by Application) 7.1 Global Neuroendocrine Carcinoma Drugs Consumption by Application 7.2 Global Neuroendocrine Carcinoma Drugs Consumption Market Share by Application (2014-2019) 8 Neuroendocrine Carcinoma Drugs Major Manufacturers Analysis 8.1 Xiaflex 8.1.1 Xiaflex Neuroendocrine Carcinoma Drugs Production Sites and Area Served 8.1.2 Xiaflex Product Introduction, Application and Specification 8.1.3 Xiaflex Neuroendocrine Carcinoma Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.1.4 Main Business and Markets Served 8.2 Novartis AG 8.2.1 Novartis AG Neuroendocrine Carcinoma Drugs Production Sites and Area Served 8.2.2 Novartis AG Product Introduction, Application and Specification 8.2.3 Novartis AG Neuroendocrine Carcinoma Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.2.4 Main Business and Markets Served 8.3 Roche 8.3.1 Roche Neuroendocrine Carcinoma Drugs Production Sites and Area Served 8.3.2 Roche Product Introduction, Application and Specification 8.3.3 Roche Neuroendocrine Carcinoma Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.3.4 Main Business and Markets Served 8.4 Molecular Insight pharmaceuticals 8.4.1 Molecular Insight pharmaceuticals Neuroendocrine Carcinoma Drugs Production Sites and Area Served 8.4.2 Molecular Insight pharmaceuticals Product Introduction, Application and Specification 8.4.3 Molecular Insight pharmaceuticals Neuroendocrine Carcinoma Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.4.4 Main Business and Markets Served 8.5 Callisto Pharmaceuticals 8.5.1 Callisto Pharmaceuticals Neuroendocrine Carcinoma Drugs Production Sites and Area Served 8.5.2 Callisto Pharmaceuticals Product Introduction, Application and Specification 8.5.3 Callisto Pharmaceuticals Neuroendocrine Carcinoma Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.5.4 Main Business and Markets Served 9 Development Trend of Analysis of Neuroendocrine Carcinoma Drugs Market 9.1 Global Neuroendocrine Carcinoma Drugs Market Trend Analysis 9.1.1 Global Neuroendocrine Carcinoma Drugs Market Size (Volume and Value) Forecast 2019-2025 9.2 Neuroendocrine Carcinoma Drugs Regional Market Trend 9.2.1 North America Neuroendocrine Carcinoma Drugs Forecast 2019-2025 9.2.2 Europe Neuroendocrine Carcinoma Drugs Forecast 2019-2025 9.2.3 China Neuroendocrine Carcinoma Drugs Forecast 2019-2025 9.2.4 Japan Neuroendocrine Carcinoma Drugs Forecast 2019-2025 9.2.5 Southeast Asia Neuroendocrine Carcinoma Drugs Forecast 2019-2025 9.2.6 India Neuroendocrine Carcinoma Drugs Forecast 2019-2025 9.3 Neuroendocrine Carcinoma Drugs Market Trend (Product Type) 9.4 Neuroendocrine Carcinoma Drugs Market Trend (Application) 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.3 Neuroendocrine Carcinoma Drugs Customers 11 Market Dynamics 11.1 Market Trends 11.2 Opportunities 11.3 Market Drivers 11.4 Challenges 11.5 Influence Factors 12 Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Author List 13.4 Disclaimer

List of Tables and Figures Figure Picture of Neuroendocrine Carcinoma Drugs Table Global Neuroendocrine Carcinoma Drugs Production (K MT) Growth Rate Comparison by Types (2014-2025) Figure Global Neuroendocrine Carcinoma Drugs Production Market Share by Types in 2018 Figure Somatostatin Analogs Product Picture Figure Targeted Therapy Product Picture Figure Chemotherapy Product Picture Table Global Neuroendocrine Carcinoma Drugs Consumption (K MT) Comparison by Applications (2014-2025) Figure Global Neuroendocrine Carcinoma Drugs Consumption Market Share by Applications in 2018 Figure Hospital Figure Clinics Figure Oncology Centres Figure Ambulatory Surgery Centres Figure Global Neuroendocrine Carcinoma Drugs Revenue (Million USD) (2014-2025) Figure Global Neuroendocrine Carcinoma Drugs Production (K MT) (2014-2025) Figure North America Neuroendocrine Carcinoma Drugs Market Size (Million USD) (2014-2025) Figure Europe Neuroendocrine Carcinoma Drugs Market Size (Million USD) (2014-2025) Figure China Neuroendocrine Carcinoma Drugs Market Size (Million USD) (2014-2025) Figure Japan Neuroendocrine Carcinoma Drugs Market Size (Million USD) (2014-2025) Figure Southeast Asia Neuroendocrine Carcinoma Drugs Market Size (Million USD) (2014-2025) Figure India Neuroendocrine Carcinoma Drugs Market Size (Million USD) (2014-2025) Table Neuroendocrine Carcinoma Drugs Raw Material and Suppliers Table Manufacturing Cost Structure Analysis of Neuroendocrine Carcinoma Drugs in 2018 Figure Manufacturing Process Analysis of Neuroendocrine Carcinoma Drugs Figure Industry Chain Structure of Neuroendocrine Carcinoma Drugs Table Capacity and Commercial Production Date of Key Manufacturers Table Global Neuroendocrine Carcinoma Drugs Manufacturing Plants Distribution Table Neuroendocrine Carcinoma Drugs Major Manufacturers Technology Source and Market Position Table Recent Development and Expansion Plans in Future Table Neuroendocrine Carcinoma Drugs Capacity (K MT) of Major Manufacturers (2014-2019) Table Neuroendocrine Carcinoma Drugs Production (K MT) of Major Manufacturers (2014-2019) Table Neuroendocrine Carcinoma Drugs Production Market Share of Major Manufacturers (2014-2019) Figure Neuroendocrine Carcinoma Drugs Production Share by Manufacturers in 2018 Table Neuroendocrine Carcinoma Drugs Revenue (Million US$) of Major Manufacturers (2014-2019) Table Neuroendocrine Carcinoma Drugs Revenue Market Share of Major Manufacturers (2014-2019) Figure Neuroendocrine Carcinoma Drugs Revenue Share by Manufacturers in 2018 Table Neuroendocrine Carcinoma Drugs Average Price (USD/MT) of Major Manufacturers (2014-2019) Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Global Neuroendocrine Carcinoma Drugs Production by Regions 2014-2019 (K MT) Table Global Neuroendocrine Carcinoma Drugs Production Market Share by Regions 2014-2019 Figure Global Neuroendocrine Carcinoma Drugs Production Market Share by Regions in 2018 Table Global Neuroendocrine Carcinoma Drugs Revenue by Regions 2014-2019 (Million USD) Table Global Neuroendocrine Carcinoma Drugs Revenue Market Share by Regions 2014-2019 Figure Global Neuroendocrine Carcinoma Drugs Revenue Market Share by Regions in 2018 Table Global Neuroendocrine Carcinoma Drugs Consumption by Regions 2014-2019 (K MT) Table Global Neuroendocrine Carcinoma Drugs Consumption Market Share by Regions 2014-2019 Figure North America Neuroendocrine Carcinoma Drugs Production Growth Rate 2014-2019 (K MT) Figure North America Neuroendocrine Carcinoma Drugs Revenue Growth Rate 2014-2019 (Million USD) Table North America Neuroendocrine Carcinoma Drugs Production, Consumption Import and Export (K MT) Figure Europe Neuroendocrine Carcinoma Drugs Production Growth Rate 2014-2019 (K MT) Figure Europe Neuroendocrine Carcinoma Drugs Revenue Growth Rate 2014-2019 (Million USD) Table Europe Neuroendocrine Carcinoma Drugs Production, Consumption Import and Export (K MT) Figure China Neuroendocrine Carcinoma Drugs Production Growth Rate 2014-2019 (K MT) Figure China Neuroendocrine Carcinoma Drugs Revenue Growth Rate 2014-2019 (Million USD) Table China Neuroendocrine Carcinoma Drugs Production, Consumption Import and Export (K MT) Figure Japan Neuroendocrine Carcinoma Drugs Production Growth Rate 2014-2019 (K MT) Figure Japan Neuroendocrine Carcinoma Drugs Revenue Growth Rate 2014-2019 (Million USD) Table Japan Neuroendocrine Carcinoma Drugs Production, Consumption Import and Export (K MT) Figure Southeast Asia Neuroendocrine Carcinoma Drugs Production Growth Rate 2014-2019 (K MT) Figure Southeast Asia Neuroendocrine Carcinoma Drugs Revenue Growth Rate 2014-2019 (Million USD) Table Southeast Asia Neuroendocrine Carcinoma Drugs Production, Consumption Import and Export (K MT) Figure India Neuroendocrine Carcinoma Drugs Production Growth Rate 2014-2019 (K MT) Figure India Neuroendocrine Carcinoma Drugs Revenue Growth Rate 2014-2019 (Million USD) Table India Neuroendocrine Carcinoma Drugs Production, Consumption Import and Export (K MT) Figure Global Consumption Neuroendocrine Carcinoma Drugs Market Share by Application (2014-2019) Figure Global Value (Consumption) Neuroendocrine Carcinoma Drugs Market Share by Application (2014-2019) Table Xiaflex Neuroendocrine Carcinoma Drugs Production Sites and Area Served Table Xiaflex Neuroendocrine Carcinoma Drugs Product Introduction, Application and Specification Table Xiaflex Neuroendocrine Carcinoma Drugs Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019) Table Xiaflex Neuroendocrine Carcinoma Drugs Production Growth Rate (2014-2019) Table Xiaflex Neuroendocrine Carcinoma Drugs Production Market Share (2014-2019) Figure Xiaflex Neuroendocrine Carcinoma Drugs Revenue Market Share (2014-2019) Table Xiaflex Neuroendocrine Carcinoma Drugs Main Business and Markets Served Table Novartis AG Neuroendocrine Carcinoma Drugs Production Sites and Area Served Table Novartis AG Neuroendocrine Carcinoma Drugs Product Introduction, Application and Specification Table Novartis AG Neuroendocrine Carcinoma Drugs Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019) Table Novartis AG Neuroendocrine Carcinoma Drugs Production Growth Rate (2014-2019) Table Novartis AG Neuroendocrine Carcinoma Drugs Production Market Share (2014-2019) Figure Novartis AG Neuroendocrine Carcinoma Drugs Revenue Market Share (2014-2019) Table Novartis AG Neuroendocrine Carcinoma Drugs Main Business and Markets Served Table Roche Neuroendocrine Carcinoma Drugs Production Sites and Area Served Table Roche Neuroendocrine Carcinoma Drugs Product Introduction, Application and Specification Table Roche Neuroendocrine Carcinoma Drugs Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019) Table Roche Neuroendocrine Carcinoma Drugs Production Growth Rate (2014-2019) Table Roche Neuroendocrine Carcinoma Drugs Production Market Share (2014-2019) Figure Roche Neuroendocrine Carcinoma Drugs Revenue Market Share (2014-2019) Table Roche Neuroendocrine Carcinoma Drugs Main Business and Markets Served Table Molecular Insight pharmaceuticals Neuroendocrine Carcinoma Drugs Production Sites and Area Served Table Molecular Insight pharmaceuticals Neuroendocrine Carcinoma Drugs Product Introduction, Application and Specification Table Molecular Insight pharmaceuticals Neuroendocrine Carcinoma Drugs Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019) Table Molecular Insight pharmaceuticals Neuroendocrine Carcinoma Drugs Production Growth Rate (2014-2019) Table Molecular Insight pharmaceuticals Neuroendocrine Carcinoma Drugs Production Market Share (2014-2019) Figure Molecular Insight pharmaceuticals Neuroendocrine Carcinoma Drugs Revenue Market Share (2014-2019) Table Molecular Insight pharmaceuticals Neuroendocrine Carcinoma Drugs Main Business and Markets Served Table Callisto Pharmaceuticals Neuroendocrine Carcinoma Drugs Production Sites and Area Served Table Callisto Pharmaceuticals Neuroendocrine Carcinoma Drugs Product Introduction, Application and Specification Table Callisto Pharmaceuticals Neuroendocrine Carcinoma Drugs Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019) Table Callisto Pharmaceuticals Neuroendocrine Carcinoma Drugs Production Growth Rate (2014-2019) Table Callisto Pharmaceuticals Neuroendocrine Carcinoma Drugs Production Market Share (2014-2019) Figure Callisto Pharmaceuticals Neuroendocrine Carcinoma Drugs Revenue Market Share (2014-2019) Table Callisto Pharmaceuticals Neuroendocrine Carcinoma Drugs Main Business and Markets Served Figure Global Neuroendocrine Carcinoma Drugs Production (K MT) Growth Rate Forecast 2019-2025 Figure Global Neuroendocrine Carcinoma Drugs Revenue (Million USD) Growth Rate Forecast 2019-2025 Figure Global Neuroendocrine Carcinoma Drugs Sales Price (USD/MT) Forecast 2019-2025 Figure North America Neuroendocrine Carcinoma Drugs Production Growth Rate Forecast 2019-2025 (K MT) Figure North America Neuroendocrine Carcinoma Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Europe Neuroendocrine Carcinoma Drugs Production Growth Rate Forecast 2019-2025 (K MT) Figure Europe Neuroendocrine Carcinoma Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure China Neuroendocrine Carcinoma Drugs Production Growth Rate Forecast 2019-2025 (K MT) Figure China Neuroendocrine Carcinoma Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Japan Neuroendocrine Carcinoma Drugs Production Growth Rate Forecast 2019-2025 (K MT) Figure Japan Neuroendocrine Carcinoma Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Southeast Asia Neuroendocrine Carcinoma Drugs Production Growth Rate Forecast 2019-2025 (K MT) Figure Southeast Asia Neuroendocrine Carcinoma Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure India Neuroendocrine Carcinoma Drugs Production Growth Rate Forecast 2019-2025 (K MT) Figure India Neuroendocrine Carcinoma Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Table Global Production (K MT) of Neuroendocrine Carcinoma Drugs by Type (2019-2025) Table Global Consumption (K MT) of Neuroendocrine Carcinoma Drugs by Application (2019-2025) Table Neuroendocrine Carcinoma Drugs Distributors List Table Neuroendocrine Carcinoma Drugs Customers List Table Market Key Trends Table Key Opportunities Table Market Key Drivers Table Key Challenges Table Key Influence Factors Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Xiaflex Novartis AG Roche Molecular Insight pharmaceuticals Callisto Pharmaceuticals